- Home
- FENG vs LGVN Comparison
FENG vs LGVN Comparison
Compare FENG & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- LGVN
- Stock Information
- Founded
- FENG 1998
- LGVN 2014
- Country
- FENG China
- LGVN United States
- Employees
- FENG N/A
- LGVN N/A
- Industry
- FENG Broadcasting
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- FENG Industrials
- LGVN Health Care
- Exchange
- FENG Nasdaq
- LGVN Nasdaq
- Market Cap
- FENG 29.7M
- LGVN 27.6M
- IPO Year
- FENG 2011
- LGVN 2021
- Fundamental
- Price
- FENG $2.25
- LGVN $1.56
- Analyst Decision
- FENG
- LGVN Strong Buy
- Analyst Count
- FENG 0
- LGVN 3
- Target Price
- FENG N/A
- LGVN $8.67
- AVG Volume (30 Days)
- FENG 6.3K
- LGVN 201.8K
- Earning Date
- FENG 03-11-2025
- LGVN 05-13-2025
- Dividend Yield
- FENG N/A
- LGVN N/A
- EPS Growth
- FENG N/A
- LGVN N/A
- EPS
- FENG N/A
- LGVN N/A
- Revenue
- FENG $96,408,461.00
- LGVN $2,392,000.00
- Revenue This Year
- FENG N/A
- LGVN $26.05
- Revenue Next Year
- FENG N/A
- LGVN $12.27
- P/E Ratio
- FENG N/A
- LGVN N/A
- Revenue Growth
- FENG 1.69
- LGVN 237.38
- 52 Week Low
- FENG $1.67
- LGVN $0.77
- 52 Week High
- FENG $4.15
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- FENG 47.35
- LGVN 45.61
- Support Level
- FENG $2.10
- LGVN $1.44
- Resistance Level
- FENG $2.33
- LGVN $1.62
- Average True Range (ATR)
- FENG 0.11
- LGVN 0.12
- MACD
- FENG -0.00
- LGVN -0.02
- Stochastic Oscillator
- FENG 50.11
- LGVN 25.00
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.